CIK 0001285819 · Non-accelerated filer<br>Smaller reporting company
OMEROS CORP
Sign in to watch- Ticker
- OMER
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 911663741
- Phone
- 206-676-5000
- Business address
- 201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,114,339
- in 5 filings, $626K under 10b5-1 plans
Net −$2,114,339. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-12 | Borges David J. VP, Finance & CAO | Sale | −30,000 | $12.72 | $382K | 0 |
| 2025-10-13 | Demopulos Gregory A MD Chairman, CEO & President | Gift | −600,000 | 1,426,986 | ||
| 2025-10-13 | Demopulos Gregory A MD Chairman, CEO & President | Gift | +300,000 | 300,000 | ||
| 2025-10-13 | Demopulos Gregory A MD Chairman, CEO & President | Gift | +300,000 | 300,000 | ||
| 2025-06-30 | Demopulos Gregory A MD Chairman, CEO & President | Grant or award · Stock Option (right to buy) | +865,000 | 865,000 | ||
| 2025-06-30 | Cancelmo Peter B VP, General Counsel | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2025-06-30 | Borges David J. VP, Finance & CAO | Grant or award · Stock Option (right to buy) | +95,000 | 95,000 | ||
| 2025-06-27 | Shah Rajiv Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2025-06-27 | Perkinson Diana T. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2025-06-27 | Hood Leroy E. MD PhD Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2025-06-27 | HANISH ARNOLD C Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2025-06-27 | Demopulos Peter A MD Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2025-06-27 | Cable Thomas J. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2025-06-27 | Bumol Thomas F. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-06-06 | Shah Rajiv Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-06-06 | Perkinson Diana T. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-06-06 | Hood Leroy E. MD PhD Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-06-06 | HANISH ARNOLD C Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-06-06 | Demopulos Peter A MD Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-06-06 | Cable Thomas J. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 |
Page 4 of 9 · 178 trades